Junk Fine But Bewar...
Health Care: Drugs
Savient Pharmaceuticals (SVNT: NASDAQ)
$0.74 0.00 | 0.46%
06/19/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 50.33M | 114.09M | 44.79M | 108.17M |
| Receivables | 4.34M | 4.74M | 909.00K | 2.36M |
| Inventories | 4.32M | 10.92M | 3.14M | 585.00K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 109.31M | 189.64M | 71.32M | 112.52M |
| Property, Plant & Equipment, Gross | 6.32M | 4.92M | 4.51M | 4.27M |
| Accumulated Depreciation & Depletion | 4.27M | 4.09M | 3.70M | 3.28M |
| Property, Plant & Equipment, Net | 2.05M | 833.00K | 809.00K | 993.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 7.84M | 6.65M | 1.28M | 1.30M |
| Total Non-Current Assets | 9.89M | 7.48M | 6.29M | 6.49M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 119.21M | 197.12M | 77.62M | 119.01M |
| Accounts Payable | 3.44M | 7.05M | 1.60M | 7.92M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.94M | 5.85M | 16.02M | 36.71M |
| Total Current Liabilities | 31.62M | 30.06M | 18.05M | 44.70M |
| Long Term Debt | 222.91M | 175.46M | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.97M | 3.00K | 10.30M | 10.11M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 225.89M | 175.46M | 10.30M | 10.11M |
| Total Liabilities | 257.50M | 205.53M | 28.35M | 54.81M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -138.30M | -8.41M | 49.27M | 64.20M |
| Common Par | 731.00K | 715.00K | 703.00K | 669.00K |
| Additional Paid In Capital | 397.19M | 408.46M | 364.14M | 305.99M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -535.92M | -417.60M | -315.58M | -242.47M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -304.00K | 15.00K | 1.00K | 3.00K |
| Total Capitalization | 84.62M | 167.05M | 49.27M | 64.20M |
| Total Equity | -138.30M | -8.41M | 49.27M | 64.20M |
| Total Liabilities & Stock Equity | 119.21M | 197.12M | 77.62M | 119.01M |
| Total Common Shares Outstanding | 73.08M | 71.50M | 70.26M | 66.93M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 70.82M | 70.12M | 67.44M | 60.00M |
| Diluted Weighted Shares Outstanding | 70.82M | 70.12M | 67.44M | 60.00M |
| Number of Employees | 122 | 173 | 129 | 43 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with SVNT
- Portfolio NameUser Type
- Usertest1123
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Stocks That Could Rise i...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Most Shorted Stocks in B...
Latest SVNT Headlines from TheStreet
- 5 Names Seeing Bullish Flow 06.06.13 | 11:06 am
- SVNT July Options Begin Trading 05.20.13 | 02:05 pm
- Arena Pharmaceuticals And 6 More Stocks To Watch 01.07.13 | 07:01 pm
- Lessons From Biotech's Best Third Quarter Stocks 10.02.12 | 09:10 am
- Savient Bulls Come Back for More 09.19.12 | 05:09 am
- 5 Stocks Under $10 Set to Soar 08.16.12 | 01:08 pm
- 5 Stocks Poised for Breakouts 08.10.12 | 01:08 pm
- Savient Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 01:08 pm
- Juicy Details From Tang Capital's Lawsuit Against Savient Pharma 05.01.12 | 03:05 pm
- Biotech Stock Mailbag: Amarin 04.23.12 | 07:04 am
Press Releases for SVNT
- Savient's KRYSTEXXA® (pegloticase) Receives European Commission Marketing Authorization For The Treatment Of Certain Patients With Chronic Tophaceous Gout - PR Newswire 01.08.13 | 11:01 am
- Savient Pharmaceuticals To Present At The 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 01.04.13 | 08:01 am
- Savient Receives Positive CHMP Opinion For KRYSTEXXA® Approval In The EU - PR Newswire 10.19.12 | 10:10 am
- Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer - PR Newswire 09.24.12 | 07:09 am
- Analysis Of KRYSTEXXA® Phase III Data Demonstrates Improved Health-Related Quality Of Life And Physical Function In Refractory Chronic Gout Patients - PR Newswire 07.02.12 | 08:07 am
- Savient Pharmaceuticals Completes Financing And Debt Restructuring Transactions - PR Newswire 05.09.12 | 03:05 pm
- Savient Pharmaceuticals And Jim Belushi Launch "Check Out Your Gout" Educational Campaign - PR Newswire 11.07.11 | 08:11 am
- Savient Pharmaceuticals Announces Publication Of Pivotal Phase III KRYSTEXXA® Data In JAMA Demonstrating Significant Benefits In Refractory Chronic Gout Patients - PR Newswire 08.16.11 | 04:08 pm
- Savient Pharmaceuticals To Present At The Wedbush Securities 2011 Life Sciences Management Access Conference - PR Newswire 08.10.11 | 04:08 pm
- Savient Pharmaceuticals To Hold Second Quarter 2011 Financial Results Conference Call On Thursday, August 4, 2011 - PR Newswire 07.20.11 | 04:07 pm
Partner Headlines for SVNT
- Perrigo expands UK presence - Financial Times 02.11.13 | 05:02 pm
- OCZ Tech: Untouchable For Now - Seeking Alpha 10.11.12 | 09:10 am
- 3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out - Seeking Alpha 09.17.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Benzinga's Microcap Movers for Friday August 24, 2012 - Benzinga 08.26.12 | 09:08 am
- Healthcare Business Review: Savient's Favorable RULING, Forest Gets FDA OKAY - Wall St. Cheat Sheet 07.24.12 | 08:07 am
- Savient Gets New CEO, Cuts Jobs - Analyst Blog - Zacks 07.10.12 | 07:07 pm
- Savient Pharmaceuticals Note Holders Claim Default -8K - Benzinga 06.09.12 | 08:06 am
- 2 Biotech Stocks To Consider Now, 1 To Avoid - Seeking Alpha 04.10.12 | 09:04 am
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.16.12 | 05:03 pm
